Matches in Nanopublications for { ?s ?p "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion description "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP378812.RAHLTJFTk3H7ZMCi6dagN_qxTGHxDxvXeKy778AYpBU2U130_assertion description "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378812.RAHLTJFTk3H7ZMCi6dagN_qxTGHxDxvXeKy778AYpBU2U130_provenance.